← Back to headlines

Takeda Drug From $4B Deal Succeeds in Two Pivotal Plaque Psoriasis Trials

This story is reported by MedCity News. Read what other outlets are saying below, then open the original report for full details.

Takeda Drug From $4B Deal Succeeds in Two Pivotal Plaque Psoriasis Trials · NabkaNews